Diego M. Fernández‐Aroca

P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy

Diego M. Fernández‐Aroca, O. Roche, S. Sabater et al. · Cancer Letters · 2019 · 64 citations · Full text

Medicine, Oncology, Pharmacology +16

Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion

Leticia Serrano‐Oviedo, Marta Ortega‐Muelas, Jesús García‐Cano et al. · PLoS ONE · 2018 · 28 citations · Full text

Life Sciences, Cell Biology, Oncology +17

p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models

Raquel Pascual‐Serra, Diego M. Fernández‐Aroca, S. Sabater et al. · Radiotherapy and Oncology · 2020 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +9

ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology

Marta Ortega‐Muelas, O. Roche, Diego M. Fernández‐Aroca et al. · Journal of Cellular and Molecular Medicine · 2021 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +17

Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential

Jorge Leal, Lucı́a Santos, Diego M. Fernández‐Aroca et al. · Journal of Inorganic Biochemistry · 2021 · 11 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10